November 29, 2011 (New York, New York) — The Angiovac endovascular clot removal system (Vortex Inc.) appears to be safe and effective for the treatment of massive pulmonary emboli and removal of large ...
LATHAM, N.Y.--(BUSINESS WIRE)-- AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, ...
(RTTNews) - Shares of medical technology firm AngioDynamics, Inc. (ANGO) are rising more than 8% in pre-market on Wednesday after the company said on Tuesday that the FDA granted Breakthrough Device ...
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, ...
Lush vegetation is great for a gardener, but alarming for a cardiologist. For them, the news that Angiodynamics Inc. received U.S. FDA breakthrough device designation for its Angiovac system to remove ...
AngioDynamics, a provider of minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, is to acquire all the outstanding capital stock of Vortex ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Recently, AngioDynamics (ANGO) inked a definitive agreement to acquire the outstanding capital stock of privately-owned Vortex Medical Inc. for $15 million in cash. The acquisition is expected to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results